In short
Millefolii herba, ethanol. infusum Ø is a herbal substance derived from yarrow (Achillea millefolium), a medicinal plant from the Asteraceae family. It is being investigated in one Phase 3 clinical trial for irritable bowel syndrome (IBS) involving 106 participants. The trial is currently authorised and compares the herbal preparation against placebo.
Key points
- Phase 3 trial investigating Millefolii herba, ethanol. infusum Ø in irritable bowel syndrome (IBS).
- 106 participants are enrolled in the trial.
- The trial compares the herbal preparation against placebo.
- The main outcome measure is change in gastrointestinal discomfort using a visual analogue scale (VAS).li>
- The trial is currently authorised and interventional in design.
What is Millefolii herba, ethanol. infusum Ø?
Millefolii herba, ethanol. infusum Ø is a herbal preparation made from yarrow (Achillea millefolium), a medicinal plant belonging to the Asteraceae family. Yarrow is one of the oldest known botanicals used by humans and is considered one of the most important medicinal plants in the pharmaceutical field. The name "Millefolii herba" refers to the herb of yarrow, while "ethanol. infusum Ø" indicates an ethanol-based infusion preparation. In the clinical trial record, this substance is also referred to as Amara-Tropfen.
How does Millefolii herba, ethanol. infusum Ø work?
Yarrow (Achillea millefolium) contains a variety of active components that have been studied for their pharmacological effects. Research has examined the pharmacodynamics, pharmacokinetics and mechanism of action of the most important components of this plant. The scientific literature discusses how these components interact with the body, including their effects on various biological pathways. The specific mechanism by which the ethanol infusion preparation may influence symptoms of irritable bowel syndrome is being investigated in the clinical trial.
Which conditions is it used or studied for?
- Irritable bowel syndrome (IBS) – a common digestive disorder causing abdominal discomfort and changes in bowel habits. The current Phase 3 trial investigates whether the herbal preparation can reduce gastrointestinal discomfort in people with this condition.
How is Millefolii herba, ethanol. infusum Ø given?
In the clinical trial, the preparation is given as Amara-Tropfen Dilution, an oral liquid taken by mouth. The dose used in the trial is 1046 microlitres (µl). This is described as an ethanol-based infusion of yarrow herb.
What do the clinical trials show?
One Phase 3 clinical trial is currently authorised to investigate this herbal preparation. The trial is an interventional study comparing the herbal preparation against placebo in 106 participants with irritable bowel syndrome.
The main measure in this trial is the change in intensity of gastrointestinal discomfort, assessed using a visual analogue scale (VAS) ranging from 0 to 100 millimetres, where 0 means no discomfort and 100 means the most intense discomfort. The trial compares the weekly mean VAS values during eight weeks of treatment against the baseline value, which is the mean of at least four VAS values documented during the seven days before starting treatment.
The trial is currently in the authorised status, meaning it has received approval to proceed. Results are not yet available in the registry record.
What side effects are known?
The available supplementary source discusses the tolerability of Achillea millefolium in general. Specific side effects of this particular preparation in the clinical trial setting have not yet been reported in the registry data. The review article indicates that yarrow has been studied for its tolerability profile, though detailed side effect information from the ongoing trial is not yet available.
